Stockreport

FDA Priority Review Puts Ionis Zilganersen At Center Of Rare-Disease Story [Yahoo! Finance]

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com
PDF Ionis Pharmaceuticals (NasdaqGS:IONS) received FDA Priority Review for its investigational therapy zilganersen for Alexander disease. The designation follows pivotal [Read more]